CA1335321C - Procede d'immunochromatographie utilisant des particules colloidales - Google Patents

Procede d'immunochromatographie utilisant des particules colloidales

Info

Publication number: CA1335321C
Authority: CA; Canada
Prior art keywords: labelled; chromatographic; reagent; zone; analyte
Prior art date: 1987-07-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

CA000616325A

Other languages

English (en)

Inventor

Shanfun Ching

Julian Gordon

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Alere Switzerland GmbH

Original Assignee

Abbott Laboratories

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-07-13

Filing date

1992-03-04

Publication date

1995-04-18

1987-07-13 Priority claimed from US07/072,459 external-priority patent/US5120643A/en

1992-03-04 Application filed by Abbott Laboratories filed Critical Abbott Laboratories

1992-03-04 Priority to CA000616325A priority Critical patent/CA1335321C/fr

1995-04-18 Application granted granted Critical

1995-04-18 Publication of CA1335321C publication Critical patent/CA1335321C/fr

2008-07-12 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

238000000034 method Methods 0.000 title claims abstract description 102
239000002245 particle Substances 0.000 title abstract description 147
238000003317 immunochromatography Methods 0.000 title description 2
108090000623 proteins and genes Proteins 0.000 claims abstract description 64
102000004169 proteins and genes Human genes 0.000 claims abstract description 62
239000000758 substrate Substances 0.000 claims abstract description 47
239000007787 solid Substances 0.000 claims abstract description 14
230000002776 aggregation Effects 0.000 claims description 10
238000004220 aggregation Methods 0.000 claims description 10
239000012736 aqueous medium Substances 0.000 claims description 5
230000002779 inactivation Effects 0.000 claims description 5
238000001035 drying Methods 0.000 claims description 4
239000000463 material Substances 0.000 abstract description 253
239000003153 chemical reaction reagent Substances 0.000 abstract description 247
239000002904 solvent Substances 0.000 abstract description 155
230000009870 specific binding Effects 0.000 abstract description 95
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 abstract description 44
239000012501 chromatography medium Substances 0.000 abstract description 33
239000003795 chemical substances by application Substances 0.000 abstract description 31
229910052737 gold Inorganic materials 0.000 abstract description 28
239000010931 gold Substances 0.000 abstract description 28
102000004190 Enzymes Human genes 0.000 abstract description 24
108090000790 Enzymes Proteins 0.000 abstract description 24
238000000159 protein binding assay Methods 0.000 abstract description 24
BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 abstract description 12
229910052711 selenium Inorganic materials 0.000 abstract description 10
239000011669 selenium Substances 0.000 abstract description 10
238000003149 assay kit Methods 0.000 abstract description 6
238000005470 impregnation Methods 0.000 abstract description 2
230000032258 transport Effects 0.000 description 141
239000000523 sample Substances 0.000 description 129
239000012491 analyte Substances 0.000 description 126
239000000243 solution Substances 0.000 description 88
238000003556 assay Methods 0.000 description 86
235000018102 proteins Nutrition 0.000 description 53
238000009739 binding Methods 0.000 description 51
238000006243 chemical reaction Methods 0.000 description 46
230000027455 binding Effects 0.000 description 38
239000000203 mixture Substances 0.000 description 38
239000000427 antigen Substances 0.000 description 37
102000036639 antigens Human genes 0.000 description 37
108091007433 antigens Proteins 0.000 description 37
238000012360 testing method Methods 0.000 description 26
239000000020 Nitrocellulose Substances 0.000 description 25
229920001220 nitrocellulos Polymers 0.000 description 25
102000011632 Caseins Human genes 0.000 description 23
108010076119 Caseins Proteins 0.000 description 23
239000005018 casein Substances 0.000 description 23
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 23
235000021240 caseins Nutrition 0.000 description 23
238000001514 detection method Methods 0.000 description 22
239000000126 substance Substances 0.000 description 20
230000004888 barrier function Effects 0.000 description 19
239000002202 Polyethylene glycol Substances 0.000 description 16
238000003018 immunoassay Methods 0.000 description 16
229920001223 polyethylene glycol Polymers 0.000 description 16
108091003079 Bovine Serum Albumin Proteins 0.000 description 14
102000011022 Chorionic Gonadotropin Human genes 0.000 description 14
108010062540 Chorionic Gonadotropin Proteins 0.000 description 14
229940098773 bovine serum albumin Drugs 0.000 description 14
229940084986 human chorionic gonadotropin Drugs 0.000 description 14
239000007788 liquid Substances 0.000 description 14
229910052751 metal Inorganic materials 0.000 description 14
239000002184 metal Substances 0.000 description 14
239000011148 porous material Substances 0.000 description 13
241000283707 Capra Species 0.000 description 12
239000000872 buffer Substances 0.000 description 12
230000037361 pathway Effects 0.000 description 12
238000011282 treatment Methods 0.000 description 12
210000002966 serum Anatomy 0.000 description 11
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 10
239000002953 phosphate buffered saline Substances 0.000 description 10
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
108010010803 Gelatin Proteins 0.000 description 9
229920000159 gelatin Polymers 0.000 description 9
239000008273 gelatin Substances 0.000 description 9
235000019322 gelatine Nutrition 0.000 description 9
235000011852 gelatine desserts Nutrition 0.000 description 9
150000002736 metal compounds Chemical class 0.000 description 9
239000002923 metal particle Substances 0.000 description 9
239000008279 sol Substances 0.000 description 9
239000000725 suspension Substances 0.000 description 9
238000012875 competitive assay Methods 0.000 description 8
239000008188 pellet Substances 0.000 description 8
229920000642 polymer Polymers 0.000 description 8
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
239000003656 tris buffered saline Substances 0.000 description 8
230000000903 blocking effect Effects 0.000 description 7
239000000975 dye Substances 0.000 description 7
230000001900 immune effect Effects 0.000 description 7
238000010324 immunological assay Methods 0.000 description 7
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
108060003951 Immunoglobulin Proteins 0.000 description 6
229920002678 cellulose Polymers 0.000 description 6
-1 gold ions Chemical class 0.000 description 6
102000018358 immunoglobulin Human genes 0.000 description 6
238000011534 incubation Methods 0.000 description 6
239000003446 ligand Substances 0.000 description 6
239000012488 sample solution Substances 0.000 description 6
229920002799 BoPET Polymers 0.000 description 5
108020004414 DNA Proteins 0.000 description 5
239000005041 Mylar™ Substances 0.000 description 5
241000283973 Oryctolagus cuniculus Species 0.000 description 5
239000002981 blocking agent Substances 0.000 description 5
FDWREHZXQUYJFJ-UHFFFAOYSA-M gold monochloride Chemical compound [Cl-].[Au+] FDWREHZXQUYJFJ-UHFFFAOYSA-M 0.000 description 5
201000005404 rubella Diseases 0.000 description 5
239000001509 sodium citrate Substances 0.000 description 5
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 5
230000003381 solubilizing effect Effects 0.000 description 5
238000003860 storage Methods 0.000 description 5
238000005406 washing Methods 0.000 description 5
102000009027 Albumins Human genes 0.000 description 4
108010088751 Albumins Proteins 0.000 description 4
108010000912 Egg Proteins Proteins 0.000 description 4
102000002322 Egg Proteins Human genes 0.000 description 4
UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
229920001213 Polysorbate 20 Polymers 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 4
239000012876 carrier material Substances 0.000 description 4
239000001913 cellulose Substances 0.000 description 4
238000000576 coating method Methods 0.000 description 4
KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 4
239000003599 detergent Substances 0.000 description 4
230000000694 effects Effects 0.000 description 4
210000003743 erythrocyte Anatomy 0.000 description 4
229940072221 immunoglobulins Drugs 0.000 description 4
150000002739 metals Chemical class 0.000 description 4
230000009871 nonspecific binding Effects 0.000 description 4
239000000123 paper Substances 0.000 description 4
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 4
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 4
229910000027 potassium carbonate Inorganic materials 0.000 description 4
230000009257 reactivity Effects 0.000 description 4
230000007928 solubilization Effects 0.000 description 4
238000005063 solubilization Methods 0.000 description 4
238000001179 sorption measurement Methods 0.000 description 4
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
241000723873 Tobacco mosaic virus Species 0.000 description 3
230000002744 anti-aggregatory effect Effects 0.000 description 3
230000000890 antigenic effect Effects 0.000 description 3
230000015572 biosynthetic process Effects 0.000 description 3
238000009835 boiling Methods 0.000 description 3
238000005119 centrifugation Methods 0.000 description 3
239000011248 coating agent Substances 0.000 description 3
239000003086 colorant Substances 0.000 description 3
230000000875 corresponding effect Effects 0.000 description 3
239000006185 dispersion Substances 0.000 description 3
150000002148 esters Chemical class 0.000 description 3
239000000499 gel Substances 0.000 description 3
238000009396 hybridization Methods 0.000 description 3
230000002209 hydrophobic effect Effects 0.000 description 3
229940127121 immunoconjugate Drugs 0.000 description 3
238000004519 manufacturing process Methods 0.000 description 3
239000002609 medium Substances 0.000 description 3
238000002156 mixing Methods 0.000 description 3
239000013642 negative control Substances 0.000 description 3
229920002113 octoxynol Polymers 0.000 description 3
239000002504 physiological saline solution Substances 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
239000000047 product Substances 0.000 description 3
230000009467 reduction Effects 0.000 description 3
230000035945 sensitivity Effects 0.000 description 3
239000007790 solid phase Substances 0.000 description 3
238000004809 thin layer chromatography Methods 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 2
102000002260 Alkaline Phosphatase Human genes 0.000 description 2
108020004774 Alkaline Phosphatase Proteins 0.000 description 2
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
102000004576 Placental Lactogen Human genes 0.000 description 2
108010003044 Placental Lactogen Proteins 0.000 description 2
239000000381 Placental Lactogen Substances 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
229930006000 Sucrose Natural products 0.000 description 2
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
241001439624 Trichina Species 0.000 description 2
229920002494 Zein Polymers 0.000 description 2
230000004520 agglutination Effects 0.000 description 2
238000007605 air drying Methods 0.000 description 2
235000011114 ammonium hydroxide Nutrition 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
239000000337 buffer salt Substances 0.000 description 2
239000007853 buffer solution Substances 0.000 description 2
125000004432 carbon atom Chemical group C* 0.000 description 2
239000007795 chemical reaction product Substances 0.000 description 2
238000004587 chromatography analysis Methods 0.000 description 2
238000003776 cleavage reaction Methods 0.000 description 2
230000009137 competitive binding Effects 0.000 description 2
230000000295 complement effect Effects 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
229940009976 deoxycholate Drugs 0.000 description 2
229960003964 deoxycholic acid Drugs 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
238000013461 design Methods 0.000 description 2
XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
238000007598 dipping method Methods 0.000 description 2
235000014103 egg white Nutrition 0.000 description 2
210000000969 egg white Anatomy 0.000 description 2
238000001493 electron microscopy Methods 0.000 description 2
238000001962 electrophoresis Methods 0.000 description 2
238000001704 evaporation Methods 0.000 description 2
230000008020 evaporation Effects 0.000 description 2
239000002657 fibrous material Substances 0.000 description 2
239000000706 filtrate Substances 0.000 description 2
239000012634 fragment Substances 0.000 description 2
239000011521 glass Substances 0.000 description 2
230000003100 immobilizing effect Effects 0.000 description 2
230000008105 immune reaction Effects 0.000 description 2
230000002452 interceptive effect Effects 0.000 description 2
238000002372 labelling Methods 0.000 description 2
238000010329 laser etching Methods 0.000 description 2
239000012528 membrane Substances 0.000 description 2
239000012229 microporous material Substances 0.000 description 2
230000005012 migration Effects 0.000 description 2
238000013508 migration Methods 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
239000000178 monomer Substances 0.000 description 2
229910052755 nonmetal Inorganic materials 0.000 description 2
230000006911 nucleation Effects 0.000 description 2
238000010899 nucleation Methods 0.000 description 2
238000004816 paper chromatography Methods 0.000 description 2
229920003023 plastic Polymers 0.000 description 2
239000004033 plastic Substances 0.000 description 2
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
108091033319 polynucleotide Proteins 0.000 description 2
102000040430 polynucleotide Human genes 0.000 description 2
239000002157 polynucleotide Substances 0.000 description 2
230000002028 premature Effects 0.000 description 2
238000000746 purification Methods 0.000 description 2
230000004044 response Effects 0.000 description 2
230000000979 retarding effect Effects 0.000 description 2
229920006395 saturated elastomer Polymers 0.000 description 2
230000007017 scission Effects 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
239000005720 sucrose Substances 0.000 description 2
229910052717 sulfur Inorganic materials 0.000 description 2
239000011593 sulfur Substances 0.000 description 2
239000006228 supernatant Substances 0.000 description 2
229910052714 tellurium Inorganic materials 0.000 description 2
PORWMNRCUJJQNO-UHFFFAOYSA-N tellurium atom Chemical compound [Te] PORWMNRCUJJQNO-UHFFFAOYSA-N 0.000 description 2
239000012085 test solution Substances 0.000 description 2
239000011782 vitamin Substances 0.000 description 2
229940088594 vitamin Drugs 0.000 description 2
229930003231 vitamin Natural products 0.000 description 2
235000013343 vitamin Nutrition 0.000 description 2
150000003722 vitamin derivatives Chemical class 0.000 description 2
239000005019 zein Substances 0.000 description 2
229940093612 zein Drugs 0.000 description 2
JKFYKCYQEWQPTM-UHFFFAOYSA-N 2-azaniumyl-2-(4-fluorophenyl)acetate Chemical compound OC(=O)C(N)C1=CC=C(F)C=C1 JKFYKCYQEWQPTM-UHFFFAOYSA-N 0.000 description 1
NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
206010003445 Ascites Diseases 0.000 description 1
108090001008 Avidin Proteins 0.000 description 1
FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical class CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
102000014914 Carrier Proteins Human genes 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
JJLJMEJHUUYSSY-UHFFFAOYSA-L Copper hydroxide Chemical compound [OH-].[OH-].[Cu+2] JJLJMEJHUUYSSY-UHFFFAOYSA-L 0.000 description 1
239000005750 Copper hydroxide Substances 0.000 description 1
230000004543 DNA replication Effects 0.000 description 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
229910021612 Silver iodide Inorganic materials 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
241000282898 Sus scrofa Species 0.000 description 1
229920004890 Triton X-100 Polymers 0.000 description 1
239000013504 Triton X-100 Substances 0.000 description 1
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
230000001133 acceleration Effects 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000009471 action Effects 0.000 description 1
230000004913 activation Effects 0.000 description 1
239000013543 active substance Substances 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
238000001261 affinity purification Methods 0.000 description 1
238000007818 agglutination assay Methods 0.000 description 1
150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
239000000908 ammonium hydroxide Substances 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
230000001745 anti-biotin effect Effects 0.000 description 1
238000011948 assay development Methods 0.000 description 1
230000008901 benefit Effects 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
108091008324 binding proteins Proteins 0.000 description 1
238000002799 binding type assay Methods 0.000 description 1
239000013060 biological fluid Substances 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
239000007975 buffered saline Substances 0.000 description 1
KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
239000004568 cement Substances 0.000 description 1
238000003486 chemical etching Methods 0.000 description 1
238000007813 chromatographic assay Methods 0.000 description 1
238000011097 chromatography purification Methods 0.000 description 1
VQWFNAGFNGABOH-UHFFFAOYSA-K chromium(iii) hydroxide Chemical compound [OH-].[OH-].[OH-].[Cr+3] VQWFNAGFNGABOH-UHFFFAOYSA-K 0.000 description 1
229940000425 combination drug Drugs 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
238000010276 construction Methods 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
239000010949 copper Substances 0.000 description 1
229910001956 copper hydroxide Inorganic materials 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
230000008878 coupling Effects 0.000 description 1
230000001808 coupling effect Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
239000008367 deionised water Substances 0.000 description 1
229910021641 deionized water Inorganic materials 0.000 description 1
230000001934 delay Effects 0.000 description 1
230000001627 detrimental effect Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
230000003292 diminished effect Effects 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
230000009881 electrostatic interaction Effects 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
239000011536 extraction buffer Substances 0.000 description 1
239000004744 fabric Substances 0.000 description 1
125000005313 fatty acid group Chemical group 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
125000000524 functional group Chemical group 0.000 description 1
238000007306 functionalization reaction Methods 0.000 description 1
PQTCMBYFWMFIGM-UHFFFAOYSA-N gold silver Chemical compound [Ag].[Au] PQTCMBYFWMFIGM-UHFFFAOYSA-N 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
239000005556 hormone Substances 0.000 description 1
210000004408 hybridoma Anatomy 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
125000004356 hydroxy functional group Chemical group O* 0.000 description 1
238000003384 imaging method Methods 0.000 description 1
239000012535 impurity Substances 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
235000014413 iron hydroxide Nutrition 0.000 description 1
NCNCGGDMXMBVIA-UHFFFAOYSA-L iron(ii) hydroxide Chemical compound [OH-].[OH-].[Fe+2] NCNCGGDMXMBVIA-UHFFFAOYSA-L 0.000 description 1
238000003698 laser cutting Methods 0.000 description 1
229910052981 lead sulfide Inorganic materials 0.000 description 1
229940056932 lead sulfide Drugs 0.000 description 1
230000031700 light absorption Effects 0.000 description 1
239000007791 liquid phase Substances 0.000 description 1
238000002761 liquid phase assay Methods 0.000 description 1
239000006193 liquid solution Substances 0.000 description 1
239000003550 marker Substances 0.000 description 1
238000007567 mass-production technique Methods 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
238000005259 measurement Methods 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
229910000000 metal hydroxide Inorganic materials 0.000 description 1
150000004692 metal hydroxides Chemical class 0.000 description 1
229910044991 metal oxide Inorganic materials 0.000 description 1
150000004706 metal oxides Chemical class 0.000 description 1
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
229920005615 natural polymer Polymers 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
229910017604 nitric acid Inorganic materials 0.000 description 1
150000002843 nonmetals Chemical class 0.000 description 1
238000007899 nucleic acid hybridization Methods 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
NQPDZGIKBAWPEJ-UHFFFAOYSA-N pentanoic acid group Chemical class C(CCCC)(=O)O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
229910052697 platinum Inorganic materials 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
238000006116 polymerization reaction Methods 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
239000008057 potassium phosphate buffer Substances 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
230000002250 progressing effect Effects 0.000 description 1
235000019260 propionic acid Nutrition 0.000 description 1
IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
230000005855 radiation Effects 0.000 description 1
239000000376 reactant Substances 0.000 description 1
238000009877 rendering Methods 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
238000013207 serial dilution Methods 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
229910052709 silver Inorganic materials 0.000 description 1
239000004332 silver Substances 0.000 description 1
ADZWSOLPGZMUMY-UHFFFAOYSA-M silver bromide Chemical compound [Ag]Br ADZWSOLPGZMUMY-UHFFFAOYSA-M 0.000 description 1
229940045105 silver iodide Drugs 0.000 description 1
238000002791 soaking Methods 0.000 description 1
239000011343 solid material Substances 0.000 description 1
241000894007 species Species 0.000 description 1
238000010186 staining Methods 0.000 description 1
239000012086 standard solution Substances 0.000 description 1
QXKXDIKCIPXUPL-UHFFFAOYSA-N sulfanylidenemercury Chemical compound [Hg]=S QXKXDIKCIPXUPL-UHFFFAOYSA-N 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
229920001059 synthetic polymer Polymers 0.000 description 1
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
239000004408 titanium dioxide Substances 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
UONOETXJSWQNOL-UHFFFAOYSA-N tungsten carbide Chemical compound [W+]#[C-] UONOETXJSWQNOL-UHFFFAOYSA-N 0.000 description 1
238000011144 upstream manufacturing Methods 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
229920003169 water-soluble polymer Polymers 0.000 description 1

Landscapes

Investigating Or Analysing Biological Materials (AREA)

CA000616325A 1987-07-13 1992-03-04 Procede d'immunochromatographie utilisant des particules colloidales Expired - Lifetime CA1335321C (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA000616325A CA1335321C (fr)	1987-07-13	1992-03-04	Procede d'immunochromatographie utilisant des particules colloidales

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US07/072,459 US5120643A (en)	1987-07-13	1987-07-13	Process for immunochromatography with colloidal particles
US072,459		1987-07-13
CA000571809A CA1306675C (fr)	1987-07-13	1988-07-12	Procede d'immunochromatographie avec particules colloidales
CA000616325A CA1335321C (fr)	1987-07-13	1992-03-04	Procede d'immunochromatographie utilisant des particules colloidales

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000571809A Division CA1306675C (fr)	1987-07-13	1988-07-12	Procede d'immunochromatographie avec particules colloidales

Publications (1)

Publication Number	Publication Date
CA1335321C true CA1335321C (fr)	1995-04-18

Family

ID=25671985

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
CA000616324A Expired - Lifetime CA1323832C (fr)	1987-07-13	1992-03-04	Processus d'immunochromatographie avec particules colloidales
CA000616325A Expired - Lifetime CA1335321C (fr)	1987-07-13	1992-03-04	Procede d'immunochromatographie utilisant des particules colloidales

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
CA000616324A Expired - Lifetime CA1323832C (fr)	1987-07-13	1992-03-04	Processus d'immunochromatographie avec particules colloidales

Country Status (1)

Country	Link
CA (2)	CA1323832C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7883899B2 (en)	2002-10-11	2011-02-08	Zbx Corporation	Diagnostic devices

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2049903B1 (fr)	2006-07-25	2015-09-09	Augurix S.A.	Dispositif d'immunochromatographie utilisé pour le diagnostic de maladies a partir d'un échantillon

1992
- 1992-03-04 CA CA000616324A patent/CA1323832C/fr not_active Expired - Lifetime
- 1992-03-04 CA CA000616325A patent/CA1335321C/fr not_active Expired - Lifetime

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7883899B2 (en)	2002-10-11	2011-02-08	Zbx Corporation	Diagnostic devices

Also Published As

Publication number	Publication date
CA1323832C (fr)	1993-11-02

Legal Events

Date	Code	Title	Description
2012-04-18	MKEX	Expiry

Publication	Publication Date	Title
US5120643A (en)	1992-06-09	Process for immunochromatography with colloidal particles
US5824268A (en)	1998-10-20	Rapid self-contained assay format
JP3358737B2 (ja)	2002-12-24	改良された投与量応答曲線を有するアッセイ
US6699722B2 (en)	2004-03-02	Positive detection lateral-flow apparatus and method for small and large analytes
JP2504923B2 (ja)	1996-06-05	免疫学的測定方法
EP0465266B1 (fr)	1995-12-13	Immunoessai avec un signal visuel complémentaire
US5081013A (en)	1992-01-14	Immunodiagnostic device and method
US7491551B2 (en)	2009-02-17	Quantitative lateral flow assays and devices
JPH0627738B2 (ja)	1994-04-13	特異的結合アッセイ装置および方法
JPH0566547B2 (fr)	1993-09-22
WO1996036878A9 (fr)	1997-01-23	Presentation de dosage rapide et autonome
PL196464B1 (pl)	2008-01-31	Analityczne urządzenie chromatograficzne oraz sposób wykrywania obecności przedmiotu analizy w próbce krwi
EP0564494B1 (fr)	1994-12-14	Procede d'essai et kit reactif associe
WO1999064863A1 (fr)	1999-12-16	Essais colorimetriques colloidaux en ecoulement continu et en ecoulement lateral utilisant des particules submicroniques solubles
CA1335321C (fr)	1995-04-18	Procede d'immunochromatographie utilisant des particules colloidales
HK1001234B (en)	1998-06-05	Test method and reagent kit therefor
HK1001234A (en)	1998-06-05	Test method and reagent kit therefor

CA1335321C - Procede d'immunochromatographie utilisant des particules colloidales - Google Patents

Info

Links

Landscapes

Priority Applications (1)

Applications Claiming Priority (4)

Related Parent Applications (1)

Publications (1)

Family

ID=25671985

Family Applications (2)

Family Applications Before (1)

Country Status (1)

Cited By (1)

Families Citing this family (1)

Cited By (1)

Also Published As

Similar Documents

Legal Events